| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 125.80× | 125.80× | 93.70× | 76.10× | 89.92× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.24× | 0.24× | 0.26× | 0.26× | 0.21× | ||
| −3.24× | −3.24× | 0.48× | −0.14× | −3.27× | ||
| −1.57× | −1.57× | 0.26× | −0.09× | −1.63× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 89.92 | 76.10 | 93.70 | 125.80 | 125.80 | |
| Asset Turnover | 0.21 | 0.26 | 0.26 | 0.24 | 0.24 | |
| Cash Conversion (CFO/Net Income) | -3.27 | -0.14 | 0.48 | -3.24 | -3.24 | |
| CFO/EBITDA | -1.63 | -0.09 | 0.26 | -1.57 | -1.57 |